Lgt Fund Management CO Ltd. Alnylam Pharmaceuticals, Inc. Transaction History
Lgt Fund Management CO Ltd.
- $1.1 Billion
- Q4 2024
A detailed history of Lgt Fund Management CO Ltd. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Lgt Fund Management CO Ltd. holds 10,070 shares of ALNY stock, worth $2.67 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
10,070Holding current value
$2.67 Million% of portfolio
0.22%Shares
1 transactions
Others Institutions Holding ALNY
# of Institutions
686Shares Held
110MCall Options Held
1.23MPut Options Held
1.19M-
Capital World Investors Los Angeles, CA16.6MShares$4.4 Billion0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$3.37 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.53 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.97MShares$1.85 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA4.2MShares$1.11 Billion0.19% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $32.6B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...